Navigation Links
Research Suggests FORTEO® Significantly Increases Bone Strength
Date:9/19/2011

TEO if it has been frozen. Do not use FORTEO after the expiration date printed on the delivery device and packaging. Throw away the FORTEO Delivery Device after 28 days even if it has medicine in it (see the User Manual).

For more safety information, please see Medication Guide (http://pi.lilly.com/us/forteo-medguide.pdf) and Prescribing Information, including Boxed Warning (http://pi.lilly.com/us/forteo-pi.pdf).  Please see full user manual that accompanies the delivery device.

TE Con ISI 07Mar2011

About Eli Lilly and Company

Eli Lilly and Company, a leading innovation-driven company, is developing a growing portfolio of pharmaceutical products by applying the latest research from its own worldwide laboratories and from collaborations with eminent scientific organizations. Headquartered in Indianapolis, Ind., Lilly provides answers -- through medicines and information -- for some of the world's most urgent medical needs. Information about Lilly is available at www.lilly.com.  P-LLY

FORTEO® is a registered trademark of Eli Lilly and Company.  

This press release contains forward-looking statements about FORTEO for the treatment of osteoporosis. It reflects Lilly's current beliefs; however, as with any such undertaking, there are substantial risks and uncertainties in the process of drug development and commercialization. There is no guarantee that future study results and patient experience will be consistent with study findings to date or that FORTEO will continue to be commercially successful. For further discussion of these and other risks and uncertainties, please see Lilly's latest Forms 10-Q and 10-K filed with the U.S. Securities and Exchange Commission. Lilly undertakes no duty to update forward-looking statements.


'/>"/>
SOURCE Eli Lilly and Company
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related medicine technology :

1. The Multiple Myeloma Research Consortium (MMRC) and Proteolix Initiate Phase 2 Clinical Trial Investigating Carfilzomib for the Treatment of Multiple Myeloma
2. Multiple Myeloma Research Consortium (MMRC) Partners with Novartis to Advance Phase II Study of Deacetylase Inhibitor
3. Lexicon to Present Research Results at American Chemical Society Meeting Regarding Target of LX1031 Drug Candidate
4. Researchers at Cleveland Clinic Identify Site of Dysfunction in HDL, Carrier of Good Cholesterol
5. Video: New Research Discovers Independent Brain Networks Control Human Walking
6. Quark Pharmaceuticals Extends Research Agreement with State University of New York for Proprietary siRNA Compounds for Acute Hearing Loss
7. Cleveland Clinic Researchers Identify Mechanism Behind Platelet Function and Potentially Fatal Blood Clot Formation
8. HistoRx and Radiation Therapy Oncology Group Initiate Brain Tumor Biomarker Research Partnership
9. Diabetes Research Institute Invention Promotes Growth of Stem Cells into Insulin-Producing Cells
10. Researchers Identify Virus Possibly Responsible for Declining Honeybee Population Using 454 Sequencing Technology from Roche
11. Peregrine Researchers Report Data Showing Bavituximabs Potential to Shrink Human Prostate Tumors in Model of Relapsed Disease
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/6/2015)... NEW YORK , July 6, 2015 ... , Chairman, will present live at VirtualInvestorConferences.com on July ... AM EDT LINK: http://tinyurl.com/e-qure-presentation ... investors are invited to ask the company questions in ... as the association,s "virtual trade booth." If attendees are ...
(Date:7/6/2015)... 2015 Array BioPharma,s (NASDAQ:   ARRY) ... weekend at the 2015 ESMO World Congress of ... meeting, data were shared from a Phase 1b ... Phase 2 expansion of that trial testing the ... with or without the addition of alpelisib (BYL719) ...
(Date:7/6/2015)... and SOUTH SAN FRANCISCO, Calif. ... (NYSE: AGN ), a leading global pharmaceutical company, ... developing novel treatments for dry eye disease, today announced ... Allergan will acquire Oculeve in an all-cash transaction.  Under ... for a $125 million upfront payment and commercialization milestone ...
Breaking Medicine Technology:E-QURE Corp to Webcast, Live, at VirtualInvestorConferences.com July 9 2Encorafenib-Based Regimens Show Promising Clinical Activity In BRAF-Mutant Colorectal Cancer Patients 2Encorafenib-Based Regimens Show Promising Clinical Activity In BRAF-Mutant Colorectal Cancer Patients 3Encorafenib-Based Regimens Show Promising Clinical Activity In BRAF-Mutant Colorectal Cancer Patients 4Allergan to Acquire Oculeve Dry Eye Disease Development Programs 2Allergan to Acquire Oculeve Dry Eye Disease Development Programs 3Allergan to Acquire Oculeve Dry Eye Disease Development Programs 4
... The U.S. Food and Drug Administration today approved ... and Zyprexa Zydus (olanzapine orally disintegrating tablets) to ... http://photos.prnewswire.com/prnh/20090824/FDALOGO ) Schizophrenia is a ... percent of Americans have this illness. Symptoms people ...
... Oct. 24, 2011 Masimo (NASDAQ: ... global manufacturer of electronic medical devices and patient ... licensing agreement and the launch of Masimo rainbow® ... of modular patient monitors. The agreement allows Biolight ...
Cached Medicine Technology:FDA Approves First Generic Olanzapine to Treat Schizophrenia, Bipolar Disorder 2FDA Approves First Generic Olanzapine to Treat Schizophrenia, Bipolar Disorder 3Guangdong Biolight Meditech Co., Ltd. Announces the Launch of Its Modular Patient Monitors with Masimo rainbow SET Pulse CO-Oximetry Technology 2Guangdong Biolight Meditech Co., Ltd. Announces the Launch of Its Modular Patient Monitors with Masimo rainbow SET Pulse CO-Oximetry Technology 3Guangdong Biolight Meditech Co., Ltd. Announces the Launch of Its Modular Patient Monitors with Masimo rainbow SET Pulse CO-Oximetry Technology 4Guangdong Biolight Meditech Co., Ltd. Announces the Launch of Its Modular Patient Monitors with Masimo rainbow SET Pulse CO-Oximetry Technology 5Guangdong Biolight Meditech Co., Ltd. Announces the Launch of Its Modular Patient Monitors with Masimo rainbow SET Pulse CO-Oximetry Technology 6
(Date:7/6/2015)... ... July 06, 2015 , ... Olive Fertility Centre is ... 2014-2015 Post Graduate Teaching Award on behalf of the department of Family Practice. , ... exciting field to be practicing in. The technology is changing so rapidly and we ...
(Date:7/6/2015)... ... July 06, 2015 , ... Cancer Hope Network (CHN) has ... medical professionals to chat with the CHN patient services team and connect with ... diagnosis is often the most traumatic experience of a person’s life,” said CHN ...
(Date:7/6/2015)... ... 2015 , ... MD Now, the leading and fastest-growing urgent care provider in ... center will serve residents and visitors in the Cutler Bay area, giving them convenient ... Florida location, the new facility will be the fourth to serve Miami-Dade County. Located ...
(Date:7/6/2015)... , ... July 06, 2015 , ... World renowned ... opportunity to achieve their ideal appearance through comprehensive treatment solutions. Individuals that want to ... the doctor and receive a plan that resolves each of their needs. , ...
(Date:7/6/2015)... ... July 06, 2015 , ... Diabetes affects many of us and the ... Americans have diabetes, the majority of which are Type 2. However, eight million do ... one in three, have prediabetes (abnormally high blood sugar levels). Without reductions in blood ...
Breaking Medicine News(10 mins):Health News:Olive Fertility Centre Physician Honoured for Teaching 2Health News:Cancer Hope Network Launches Upgraded Website to Support Cancer Patients, Caregivers 2Health News:MD Now Urgent Care Opens its Fourth Miami-Dade County Facility in Cutler Bay 2Health News:MD Now Urgent Care Opens its Fourth Miami-Dade County Facility in Cutler Bay 3Health News:Los Angeles Plastic Surgeon, Dr. Paul Nassif, is Now Offering Comprehensive Facial Plastic Surgery Procedures 2Health News:115 Million in the U.S. could beat diabetes with the help of a new app 2
... the structure of a key part of the human obesity ... which could help provide new treatments for the complications of ... in the journal Structure , will greatly enhance the ... the receptor for the obesity hormone leptin. This could have ...
... of Wildlife Ecology (FIWI) of the University of Veterinary ... set on common dormice ( Muscardinus avellanarius ) to ... rodents are about the size and weight of a ... rodent cousins, they hibernate usually from late September/October ...
... By Jenifer Goodwin HealthDay Reporter , THURSDAY, ... a toddler, Abby Mahoney,s parents knew she was different. She ... detailed theories about why they became extinct. Abby ... an intelligent child would crawl under her desk while the ...
... CAMBRIDGE, Mass. -- In this week,s issue of the ... Boston hospitals provide early evidence that a simple, unobtrusive ... as accurately as electroencephalograms (EEGs) do but without ... could make it possible to collect clinically useful data ...
... HealthDay Reporter , WEDNESDAY, April 25 (HealthDay News) -- Aromatherapy ... diverse as the American Cancer Society and the U.S. Department ... therapy that can complement traditional health care. There,s little ... research has found it can help reduce a wide range ...
... an association between the rs1051730-rs16969968 genotype and objective measures ... is largely, if not entirely, mediated by level of ... in the Journal of the National Cancer Institute ... associated with heaviness of smoking, lung cancer risk, and ...
Cached Medicine News:Health News:New drug to tackle fat problems 2Health News:When to have kids: A complex question for hazel dormice 2Health News:Battling the Bullying of an Autistic Child 2Health News:Battling the Bullying of an Autistic Child 3Health News:Battling the Bullying of an Autistic Child 4Health News:Gauging seizures' severity 2Health News:Gauging seizures' severity 3Health News:Aromatherapy: More Than Just a Pleasant Scent? 2Health News:Aromatherapy: More Than Just a Pleasant Scent? 3Health News:Genetic variants, tobacco exposure and lung cancer risk 2
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
Medicine Products: